Company Filing History:
Years Active: 2023-2025
Title: Innovations of Peter A Goldstein
Introduction
Peter A Goldstein is a notable inventor based in Hartsdale, NY (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that modulate HCN channels. With a total of 2 patents to his name, Goldstein's work has the potential to impact the treatment of various HCN-related disorders.
Latest Patents
Goldstein's latest patents focus on "Substituted alkylphenols as HCN1 antagonists." These patents describe compounds that modulate HCN channels, which are essential intermembrane proteins functioning as nonselective voltage-gated cation channels in the plasma membranes of heart and brain cells. The patents also detail pharmaceutical compositions and kits that include these compounds, along with methods for treating HCN-related disorders, such as pain, by administering the described compounds and compositions.
Career Highlights
Goldstein is affiliated with Cornell University, where he continues to advance his research and innovation in the field of pharmacology. His work is characterized by a commitment to developing effective treatments for complex medical conditions.
Collaborations
Some of Goldstein's notable coworkers include Gareth R Tibbs and Anthony A Sauve. Their collaborative efforts contribute to the ongoing research and development of innovative solutions in the pharmaceutical industry.
Conclusion
Peter A Goldstein's contributions to the field of pharmaceuticals through his patents and research at Cornell University highlight his role as an influential inventor. His work in developing HCN channel modulators has the potential to lead to significant advancements in medical treatments.